相似文献
1
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward.
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):531. doi: 10.1016/S2468-1253(20)30089-3. Epub 2020 Mar 30.
2
Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification.
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):642-643. doi: 10.1016/S2468-1253(20)30124-2. Epub 2020 Apr 22.
3
Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.
Am J Clin Pathol. 2020 Jul 7;154(2):278-279. doi: 10.1093/ajcp/aqaa092.
4
Challenges and issues of SARS-CoV-2 pool testing.
Lancet Infect Dis. 2020 Nov;20(11):1233-1234. doi: 10.1016/S1473-3099(20)30467-9. Epub 2020 Jul 14.
5
Challenges and issues of SARS-CoV-2 pool testing.
Lancet Infect Dis. 2020 Nov;20(11):1233. doi: 10.1016/S1473-3099(20)30463-1. Epub 2020 Jul 14.
6
Challenges and issues of SARS-CoV-2 pool testing.
Lancet Infect Dis. 2020 Nov;20(11):1232-1233. doi: 10.1016/S1473-3099(20)30516-8. Epub 2020 Jul 14.
7
SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19.
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):958-960. doi: 10.1016/S2468-1253(20)30293-4. Epub 2020 Sep 18.
8
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
9
Challenges and issues of SARS-CoV-2 pool testing - Authors' reply.
Lancet Infect Dis. 2020 Nov;20(11):1234-1235. doi: 10.1016/S1473-3099(20)30455-2. Epub 2020 Jul 14.
10
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Am J Clin Pathol. 2020 Apr 15;153(5):567-570. doi: 10.1093/ajcp/aqaa047.
引用本文的文献
1
Assuring safety of fecal microbiota transplantation in the COVID-19 era: A single-center experience.
JGH Open. 2023 Oct 20;7(11):765-771. doi: 10.1002/jgh3.12979. eCollection 2023 Nov.
2
Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation.
Heliyon. 2023 Jun;9(6):e17438. doi: 10.1016/j.heliyon.2023.e17438. Epub 2023 Jun 18.
3
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci. 2023 Mar 24;24(7):6123. doi: 10.3390/ijms24076123.
4
Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
Saudi J Gastroenterol. 2023 Jan-Feb;29(1):3-11. doi: 10.4103/sjg.sjg_131_22.
5
Current Trends and Challenges of Fecal Microbiota Transplantation-An Easy Method That Works for All?
Biomedicines. 2022 Oct 28;10(11):2742. doi: 10.3390/biomedicines10112742.
6
Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies.
Front Cell Infect Microbiol. 2021 Nov 18;11:753444. doi: 10.3389/fcimb.2021.753444. eCollection 2021.
7
Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review.
JGH Open. 2021 Oct 26;5(11):1257-1265. doi: 10.1002/jgh3.12671. eCollection 2021 Nov.
8
Transmission of severe acute respiratory syndrome coronavirus 2 fecal-oral: Current knowledge.
World J Clin Cases. 2021 Oct 6;9(28):8280-8294. doi: 10.12998/wjcc.v9.i28.8280.
9
High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong.
United European Gastroenterol J. 2021 Nov;9(9):1027-1038. doi: 10.1002/ueg2.12160. Epub 2021 Oct 8.
10
Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissions.
F1000Res. 2021 May 11;10:373. doi: 10.12688/f1000research.52178.1. eCollection 2021.
本文引用的文献
1
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.
Nat Med. 2020 Apr;26(4):502-505. doi: 10.1038/s41591-020-0817-4. Epub 2020 Mar 13.
2
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel.
Lancet Gastroenterol Hepatol. 2020 May;5(5):430-432. doi: 10.1016/S2468-1253(20)30082-0. Epub 2020 Mar 17.
3
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
4
Presumed Asymptomatic Carrier Transmission of COVID-19.
JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.
5
STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.
BMJ Open. 2019 Nov 11;9(11):e030659. doi: 10.1136/bmjopen-2019-030659.
6
The use of faecal microbiota transplant as treatment for recurrent or refractory infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Gut. 2018 Nov;67(11):1920-1941. doi: 10.1136/gutjnl-2018-316818. Epub 2018 Aug 28.
Zotero 插件